BioPharma APAC

INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment...

May 17, 2022 | News

INEX Innovate receives EU CE-IVD Certification to detect cancer in ovarian cysts

Revolutionary Ovarian Cancer Rapid Test Available Q4 2022 Known as a pioneer in Asia's women's and fetal health industry, Singapore-ba...

May 12, 2022 | News

Obesity epidemic impacts on fertility, but denying women treatment based on weight is discriminatory

Overweight or obese women are at greater risk of menstrual dysfunction or pregnancy related difficulties, and those with excessive body mass index (BMI) un...

May 03, 2022 | News

AHF Praises Merck for Generics – Urges Same from Vaccine Makers

“We praised Merck last October for its voluntary licensing agreement with MPP. Their efforts are now coming to fruition with an affordable ...

January 25, 2022 | News

5 Ways to Help Reduce the Risk of Birth Defects

Each year, birth defects affect about 1 in 33 babies born in the United States, according to the U.S. Centers for Disease Control and Prev...

January 04, 2022 | News

Linepharma International Files for Manufacturing, Marketing Approval of the Abortion Pill in Japan

The medication is recognized as the international gold standard for first trimester medical abortioni and is on the World Health Organization (WH...

December 23, 2021 | News

Smart fertility test gets green light for home and professional use

Swiss medtech company Bloom Diagnostics today announced European approval for its Bloom Ovarian Reserve Test, measuring AMH (Anti-Müllerian Hormone) u...

December 14, 2021 | News

Indonesia Bring New Hope to Women With Endometriosis

Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today ...

October 07, 2021 | News

SynForU™-HerCare is effective in reducing vulvovaginal symptoms in pregnant women.

The first clinical study which has been published in the Journal of Applied Microbiology documents that SynForU™-HerCare is effective in reducing vul...

September 01, 2021 | News

MedAlliance Enrolls First Patient in Erectile Dysfunction Study with Sirolimus Drug Eluting Balloon

The aim of the study is to assess the feasibility and safety of angioplasty with a sirolimus-eluting balloon in patients with ED and distal interna...

August 19, 2021 | News

BioCheck Inc Acquires DRG International Inc, a leading IVD company

BioCheck, Inc. has announced that it has acquired DRG International, a leading manufacturer of clinical diagnostic and research ELISAs...

August 19, 2021 | News

UKM collaborated in an international study of mortality rates for babies with birth defects

Senior Consultant Paediatric Surgeon at the Faculty of Medicine UKM, Professor Dr. Dayang Anita Abdul Aziz served as institutional, country and the regio...

August 12, 2021 | News

Menarini APAC strengthens Men's Health portfolio in China

Acquisition of Cialis® in the People's Republic of China to bolster Menarini's Men's Health portfolio and drive multichannel coverage This...

July 22, 2021 | News

Lupin Announces FDA Approval for SOLOSEC® to Combat STD's

SOLOSEC® demonstrated a 92.2% clinically and statistically significant cure rate for patients with trichomoniasis based on a landmark Phase 3 clinical ...

July 04, 2021 | News

Stay Connected